Filter
1041
Filtered Results: 1041
Text search:
E.coli
Featured
Recommendations
126
New Publications
217
Language
Document type
No document type
459
Guidelines
238
Studies & Reports
204
Manuals
56
Strategic & Response Plan
31
Fact sheets
21
Training Material
19
Situation Updates
8
Brochures
4
Resource Platforms
1
Countries / Regions
India
41
Global
32
Latin America and the Carribbean
27
Western and Central Europe
24
Paraguay
20
Kenya
18
South Africa
18
Ethiopia
17
Africa
16
Nepal
13
Rwanda
13
Brazil
13
Mozambique
12
Colombia
12
Russia
12
Indonesia
11
Argentina
11
Myanmar / Burma
11
Senegal
10
Uganda
10
Philippines
10
Bangladesh
10
Venezuela
10
Congo, Democratic Republic of
9
Malawi
9
Peru
9
Eastern Europe
9
Ghana
8
Germany
8
Benin
8
Ukraine
8
Sierra Leone
7
Tanzania
7
Bolivia
7
Burkina Faso
6
Cameroon
6
Haiti
6
Angola
6
Nigeria
5
Zimbabwe
5
Liberia
4
Mali
4
Thailand
4
Eswatini/ Swaziland
4
Guinea
3
Guinea-Bissau
3
South Sudan
3
Ecuador
3
El Salvador
3
Madagascar
3
Lesotho
3
West and Central Africa
3
South–East Asia Region
3
Spain
3
USA
2
Somalia
2
Pakistan
2
Jordan
2
Zambia
2
Syria
2
Honduras
2
Nicaragua
2
Chile
2
Yemen
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Romania
2
Vietnam
2
Gabon
2
Uruguay
2
France
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Niger
1
Iraq
1
Cambodia
1
Singapore
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
North Macedonia
1
Burundi
1
Botswana
1
Libya
1
Guatemala
1
Mexico
1
East and Southern Africa
1
Asia
1
Southern Africa
1
Laos
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
334
Clinical Guidelines
89
Key Resources
73
Women & Child Health
68
Public Health
30
Capacity Building
21
Pharmacy & Technologies
17
Toolboxes
AMR
220
COVID-19
81
Mental Health
61
Planetary Health
56
TB
45
Pharmacy
37
Caregiver
29
Disability
28
Rapid Response
24
NTDs
21
Natural Hazards
19
Cholera
18
HIV
17
Ebola
15
Global Health Education
15
Conflict
13
NCDs
11
Refugee
10
Specific Hazards
4
Zika
3
Social Ethics
2
Health Financing Toolbox
2
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
L’antibiorésistance constitue aujourd’hui l’un des grands défis à relever à l’échelle mondiale. Il s’agit d’une menace de santé publique majeure qui impose une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin d...
WHO recommends member states provide universal access to public hand hygiene stations and making their use obligatory on entering and leaving any public or private commercial building and any public transport facility. It is also recommended that healthcare facilities improve access to and practice ...
Current evidence indicates that the COVID-19 virus is transmitted through respiratory droplets or contact. Contact transmission occurs when contaminated hands touch the mucosa of the mouth, nose, or eyes; the virus can also be transferred from one surface to another by contaminated hands, which fac...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
ПРАКТИЧЕСКИЕ ШАГИ ПО ОБЕСПЕЧЕНИЮ ВСЕОБЩЕГО ДОСТУПА К КАЧЕСТВЕННОЙ ПОМОЩИ
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
Características farmacológicas y clínicas más relevantes de los Medicamentos Esenciales utilizados en el manejo de las enfermedades infecciosas prevalentes en el primer nivel de atención. La misma se agrupa a su vez en: antibióticos, antimicóticos, antivirales, antiparasitarios y fármacos pa...
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
During fresh fruit and vegetables (FFV) production, water is used for a variety of purposes. Even the water was conventionally treated and disinfected, it may still potentially contain human pathogens, albeit at low concentrations. A risk assessment, appropriate to the national or local production c...
Plan Estratégico
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
